Status:
UNKNOWN
Clinical Evaluation of Removing Blood Stasis Therapy in Treating Acute Cerebral Hemorrhage Safety and Efficacy
Lead Sponsor:
Guangzhou University of Traditional Chinese Medicine
Collaborating Sponsors:
Lianjiang people's Hospital
Shenyang Second Hospital of traditional Chinese Medicine
Conditions:
Intracerebral Hemorrhage, Hypertensive
Traditional Chinese Medicine
Eligibility:
All Genders
18-80 years
Phase:
PHASE4
Brief Summary
The purpose of this research is to use the "Removing Blood Stasis Decotion" of traditional Chinese medicine treating the acute stage of cerebral hemorrhage with stroke associated pneumonia to explore ...
Detailed Description
objective: to investigate the impact and immunologic mechanism of using the "Removing Blood Stasis Decotion" treatment in SAP after Acute Cerebral Hemorrhage with the concept of Intestinal Micro Ecolo...
Eligibility Criteria
Inclusion
- Greater than or equal to 18 years old while younger than 80 years old
- acute cerebral hemorrhage confirmed by brain CT scan within 6 to72 hours from onset
- GCS≥6
- Sign the informed consent form
Exclusion
- Tests have confirmed that cerebral hemorrhage caused by brain tumor, blood diseases, cerebrovascular malformation (anomaly) or aneurysm, etc;
- patients with Severe heart, liver and renal insufficiency.
- Intolerance to traditional Chinese medicine (TCM), allergic constitution.
- patients with severe cerebral hernia in the early onset
- Compliance is poor.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT03354026
Start Date
November 1 2017
End Date
December 1 2022
Last Update
November 27 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Provincial Science and Technology Agency
Guangzhou, Guangdong, China, 510033
2
Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, Guangdong, China, 510120